MARIA LUISA
FERRANDIZ MANGLANO
CATEDRÀTIC/A D'UNIVERSITAT
Universidad Politécnica de Valencia
Valencia, EspañaPublications in collaboration with researchers from Universidad Politécnica de Valencia (8)
2024
-
New Insights into the Pro-Inflammatory and Osteoclastogenic Profile of Circulating Monocytes in Osteoarthritis Patients
International Journal of Molecular Sciences, Vol. 25, Núm. 3
2022
-
Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1
International journal of molecular sciences, Vol. 23, Núm. 15
2020
-
Relevance of Nrf2 and heme oxygenase-1 in articular diseases
Free Radical Biology and Medicine, Vol. 157, pp. 83-93
2019
-
Emerging therapeutic agents in osteoarthritis
Biochemical Pharmacology, Vol. 165, pp. 4-16
-
Osteostatin inhibits collagen-induced arthritis by regulation of immune activation, pro-inflammatory cytokines, and osteoclastogenesis
International Journal of Molecular Sciences, Vol. 20, Núm. 16
2018
-
Myeloid heme oxygenase-1 regulates the acute inflammatory response to zymosan in the mouse air pouch
Oxidative Medicine and Cellular Longevity, Vol. 2018
-
Nrf2 as a therapeutic target for rheumatic diseases
Biochemical Pharmacology, Vol. 152, pp. 338-346
2017
-
Targeting inflammasome by the inhibition of caspase-1 activity using capped mesoporous silica nanoparticles
Journal of Controlled Release, Vol. 248, pp. 60-70